Thyroid
Molecular diagnostics and targeted therapies, such as tyrosine kinase inhibitors, have significantly improved the prognosis of advanced and recurrent thyroid cancers.
MEDICAL XPRESS
Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients
Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who
April 28, 2025
HEALTH DAY
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of Treatment
THURSDAY, Jan. 30, 2025 (HealthDay News) — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1
February 4, 2025
HEALTH DAY
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an
January 26, 2025
